Potentially Resectable ALK Positive Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Potentially Resectable ALK Positive Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial (NCT06282536) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-03-01 |
Track Potentially Resectable ALK Positive Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.